Quick Answer: The Bayh-Dole Act, passed by Congress in 1980, lets universities and research institutions patent discoveries made with federal funding and license them to private companies. That pathway is how the CMOS image sensor, first developed as a "camera-on-a-chip" at NASA's Jet Propulsion Laboratory, reached the phones, cars, and medical devices people use daily. Proposed changes to the law could make that route harder to follow.
Your phone camera started as a government research project. The chip that captures your photos traces back to a lab in Pasadena and to a 1980 federal law that most people have never heard of. The Bayh-Dole Act is the reason a lab breakthrough could become a product that billions of people carry. Eric Fossum, who led the work at NASA's Jet Propulsion Laboratory (JPL), argues in a State-Journal guest column published November 9, 2026, that policymakers should think hard before touching it.
From a Lab Prototype to a Chip in Your Phone
In the 1990s, Fossum's team at JPL developed what he calls a "camera-on-a-chip." It put much of a camera's functionality onto a single semiconductor. The result was the complementary metal-oxide-semiconductor (CMOS) image sensor.
Before CMOS, most digital cameras relied on charge-coupled devices (CCDs). CCDs produce excellent images but draw more power and need more support circuitry. CMOS sensors can be manufactured on standard chip production lines, which lowers cost and lets engineers add processing directly on the chip. Those advantages explain why CMOS now dominates consumer imaging.
Here's the part most histories skip: the invention was never the bottleneck. A working prototype in a government lab doesn't sell itself. It needs money, years of refinement, and a company willing to bet on it. The gap between a proof of concept and a shipping product is where most promising technologies die.
What the Bayh-Dole Act Actually Does
Congress passed the Bayh-Dole Act in 1980 to close that gap. Before it, many inventions funded by the federal government stayed stuck in agency hands, with unclear licensing paths. The law changed the default. It let universities and other nonprofit research institutions own patents on discoveries made with federal support, then license them to commercial partners.
The mechanics look like this:
- A researcher makes a discovery using federal grant money.
- The institution discloses the invention and decides whether to patent it.
- The institution licenses the patent, often exclusively, to a company or startup.
- The licensee funds development, manufacturing, and sales.
- The government keeps a non-exclusive license for its own use, plus march-in rights that let agencies step in if the licensee fails to bring the invention to market.
That last point matters. March-in rights are a backstop. They give the government leverage if a patent sits unused, without making the government the default owner or decision-maker. Critics sometimes say the system gives universities too much control. Defenders say the arrangement works because it puts decisions with the people closest to the technology.
How One License Turned Into a Business
Fossum's own story shows the law in action. After leaving JPL, he co-founded Photobit Corporation to commercialize the imaging technology. Caltech, which operates JPL, granted Photobit an exclusive license to the relevant patents.
That exclusivity wasn't a formality. Investors don't fund a company that competitors can copy the next day. With secure rights, Photobit could raise capital, keep improving the sensors, and make a case to camera makers that CMOS could compete with the CCD technology that dominated the market.
Here's the counter-intuitive part. Most people assume the hard problem was technical, and once the sensor worked, the market would take care of itself. In practice, the bottleneck was financial and legal. Manufacturers wanted proof that the technology would hold up and that the supplier would still exist in five years. The license gave Photobit the legal footing to make those promises.
Today, manufacturers produce roughly seven billion CMOS image sensors a year, according to Fossum. That scale is the payoff of a patent system designed to move research into private hands.
The Numbers Behind the Framework
Fossum points to figures that go beyond one company. He writes that since 1980, Bayh-Dole technology transfer has helped create more than 21,000 startups and generated nearly $2 trillion in economic activity. Those are his numbers, and they're the kind of economic-impact estimates that depend heavily on how you define "activity." Treat them as the author's estimate rather than an independently audited total.
Even with that caveat, the direction of the argument is clear. The law has become a core mechanism for turning federally funded research into commercial products. Universities now run technology transfer offices, licensing staff, and startup support programs partly because the Bayh-Dole framework rewards them for doing so.
Most people stop here, but the real question is what happens if the framework changes. That's where the column gets specific.
What the Proposed Changes Could Break
Fossum describes two developments in policy debates. One federal agency has proposed taking a more direct role in decisions about licensing inventions it helped support. A federal research agency detailee has suggested dropping the Bayh-Dole model entirely. The column doesn't name either agency, and the proposals aren't final.
Why would a licensing change matter so much? Because commercialization is slow and expensive, and the people funding it need predictable rights. Here's the problem in concrete terms:
- Years of spending with no guaranteed return. Developing a sensor, drug, or device can take a decade before it reaches consumers.
- Shifting ownership or licensing rights. An investor who signs a deal today needs to know the license won't be reassigned tomorrow.
- Added approval layers. Each new government decision point adds delay and legal risk.
The uncertainty is the cost. Government control can look like a way to protect taxpayers, and sometimes it is. But every new unknown raises the return investors demand before they'll commit. When that happens, some promising projects simply never get funded.
That said, there's a real case for reform. Some critics argue that exclusive licenses can leave useful technology sitting on a shelf or priced out of reach. Those concerns deserve a serious answer. The trade-off is whether the fix is a narrow adjustment or a wholesale rewrite.
Comparing the Current Model With Proposed Alternatives
The table below summarizes how the existing framework differs from the direction the proposals point toward, based on the column's description and the statute's existing provisions.
| Feature | Current Bayh-Dole model (since 1980) | Proposed direct agency role or repeal |
|---|---|---|
| Who decides on licensing | Universities and nonprofit research institutions | Federal agencies (in the direct-role proposal) or no framework (in repeal) |
| Patent ownership | Institution may patent federally funded inventions | Would change under the proposals; the column warns this is the uncertainty |
| Government backstop | Non-exclusive government license and march-in rights | Not specified in the column; would depend on the final design |
| Investor certainty | Exclusive licenses give licensees a stable basis to raise capital | Rights could shift during development, per Fossum's argument |
The right choice depends on what you're optimizing for. If your priority is faster, more flexible control of federal inventions, a direct agency role might appeal. If your priority is predictable private investment in early-stage technology, the existing framework has a track record the column documents.
Frequently Asked Questions
What is the Bayh-Dole Act?
The Bayh-Dole Act is a 1980 federal law that lets universities and nonprofit research institutions own patents on inventions made with federal research funding. They can then license those patents to companies for commercial development. The government keeps a non-exclusive license and march-in rights if a licensee doesn't bring the invention to market.
What is a CMOS image sensor?
A CMOS image sensor is a semiconductor chip that converts light into digital image data. It integrates much of the camera's circuitry onto one chip. Developed further from NASA JPL's "camera-on-a-chip" work, CMOS sensors now dominate phones, computers, and many cars.
How does the Bayh-Dole Act affect new technology?
It creates a pathway from federally funded lab research to private investment. Companies can secure exclusive licenses, which give them the legal certainty to raise money and build products. Without that pathway, many inventions would stay in government hands with no clear route to market.
Can the government take back a patent under Bayh-Dole?
Yes, under limited conditions. March-in rights let a federal agency require a licensee to grant licenses to others, or in some cases take other steps, if the invention isn't being made available to the public. Agencies have rarely used this power, and the process is designed as a backstop rather than routine oversight.
Don't Let the Pipeline Break
The lesson from Fossum's career is simple: a breakthrough isn't a product until someone can afford to take the risk of building it. The Bayh-Dole Act works because it gives inventors and investors a stable path from federal lab to market. If you work in research, startups, or tech policy, read the proposed changes closely and ask who bears the risk when licensing rights shift. Try this week: find one federally funded invention in your field, trace its licensing history, and note how long it took to reach users. That single example will tell you more about the Bayh-Dole Act than any debate.